{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:59:02Z","timestamp":1782741542711,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40123-026-01408-y","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:58:03Z","timestamp":1780459083000},"page":"2365-2378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Multimodal Approach to Open-Angle Glaucoma with Travoprost Intracameral Implant and Minimally Invasive Glaucoma Surgery with or Without Concurrent Cataract Surgery"],"prefix":"10.1007","volume":"15","author":[{"given":"Christine","family":"Funke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"CoHan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"Suppl 2","key":"1408_CR1","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.4103\/IJO.IJO_517_24","volume":"73","author":"AWJ Teo","year":"2025","unstructured":"Teo AWJ, Angmo D, Wong TTL, Nongpiur ME. Interventional glaucoma: rethinking glaucoma treatment paradigms in the Asian context. Indian J Ophthalmol. 2025;73(Suppl 2):S207\u201313.","journal-title":"Indian J Ophthalmol"},{"issue":"12","key":"1408_CR2","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/j.jcrs.0000000000001537","volume":"50","author":"JM Micheletti","year":"2024","unstructured":"Micheletti JM, Brink M, Brubaker JW, Ristvedt D, Sarkisian SR. Standalone interventional glaucoma: evolution from the combination-cataract paradigm. J Cataract Refract Surg. 2024;50(12):1284\u201390.","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"1408_CR3","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1007\/s40123-023-00831-9","volume":"12","author":"NM Radcliffe","year":"2023","unstructured":"Radcliffe NM, Shah M, Samuelson TW. Challenging the \u2018topical medications-first\u2019 approach to glaucoma: a treatment paradigm in evolution. Ophthalmol Ther. 2023;12(6):2823\u201339.","journal-title":"Ophthalmol Ther"},{"issue":"2","key":"1408_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/ICU.0000000000000927","volume":"34","author":"N Radcliffe","year":"2023","unstructured":"Radcliffe N. The case for standalone micro-invasive glaucoma surgery: rethinking the role of surgery in the glaucoma treatment paradigm. Curr Opin Ophthalmol. 2023;34(2):138\u201345.","journal-title":"Curr Opin Ophthalmol"},{"issue":"5S","key":"1408_CR5","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.ogla.2025.06.010","volume":"8","author":"T Realini","year":"2025","unstructured":"Realini T, Gazzard G. Selective laser trabeculoplasty and the evolving glaucoma paradigm. Ophthalmol Glaucoma. 2025;8(5S):S38\u201344.","journal-title":"Ophthalmol Glaucoma"},{"issue":"1","key":"1408_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/OPX.0b013e3182058ead","volume":"88","author":"T Realini","year":"2011","unstructured":"Realini T. A history of glaucoma pharmacology. Optom Vis Sci. 2011;88(1):36\u20138.","journal-title":"Optom Vis Sci"},{"issue":"4","key":"1408_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.5301\/EJO.2010.6112","volume":"21","author":"GCM Rossi","year":"2011","unstructured":"Rossi GCM, Pasinetti GM, Scudeller L, Radaelli R, Bianchi PE. Do adherence rates and glaucomatous visual field progression correlate? Eur J Ophthalmol. 2011;21(4):410\u20134.","journal-title":"Eur J Ophthalmol"},{"issue":"12","key":"1408_CR8","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1016\/j.ophtha.2011.05.013","volume":"118","author":"B Sleath","year":"2011","unstructured":"Sleath B, Blalock S, Covert D, et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology. 2011;118(12):2398\u2013402.","journal-title":"Ophthalmology"},{"issue":"6","key":"1408_CR9","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ophtha.2004.12.035","volume":"112","author":"CMG Olthoff","year":"2005","unstructured":"Olthoff CMG, Schouten JSAG, Van De Borne BW, Webers CAB. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension: an evidence-based review. Ophthalmology. 2005;112(6):953-961.e7.","journal-title":"Ophthalmology"},{"issue":"2","key":"1408_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0002-9394(14)71282-6","volume":"116","author":"WC Stewart","year":"1993","unstructured":"Stewart WC, Chorak RP, Hunt HH, Sethuraman G. Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol. 1993;116(2):176\u201381.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"1408_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0002-9394(14)74225-4","volume":"103","author":"MA Kass","year":"1987","unstructured":"Kass MA, Gordon M, Morley RE, Meltzer DW, Goldberg JJ. Compliance with topical timolol treatment. Am J Ophthalmol. 1987;103(2):188\u201393.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1408_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ophtha.2019.10.022","volume":"127","author":"PA Newman-Casey","year":"2020","unstructured":"Newman-Casey PA, Niziol LM, Gillespie BW, Janz NK, Lichter PR, Musch DC. The association between medication adherence and visual field progression in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2020;127(4):477\u201383.","journal-title":"Ophthalmology"},{"issue":"2","key":"1408_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.joco.2017.09.002","volume":"30","author":"K Rajurkar","year":"2018","unstructured":"Rajurkar K, Dubey S, Gupta PP, John D, Chauhan L. Compliance to topical anti-glaucoma medications among patients at a tertiary hospital in North India. J Curr Ophthalmol. 2018;30(2):125\u20139.","journal-title":"J Curr Ophthalmol"},{"issue":"10180","key":"1408_CR14","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(18)32213-X","volume":"393","author":"G Gazzard","year":"2019","unstructured":"Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet. 2019;393(10180):1505\u201316.","journal-title":"Lancet"},{"issue":"2","key":"1408_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ophtha.2022.09.009","volume":"130","author":"G Gazzard","year":"2023","unstructured":"Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Laser in glaucoma and ocular hypertension (LiGHT) trial: six-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension. Ophthalmology. 2023;130(2):139\u201351.","journal-title":"Ophthalmology"},{"key":"1408_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2147\/OPTH.S84996","volume":"10","author":"J Song","year":"2016","unstructured":"Song J. Complications of selective laser trabeculoplasty: a review. Clin Ophthalmol. 2016;10:137.","journal-title":"Clin Ophthalmol"},{"key":"1408_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ajo.2024.12.026","volume":"272","author":"M Kolko","year":"2025","unstructured":"Kolko M, Tatham AJ, Lim KS, et al. Phase\u00a03, randomized, comparison study of intracameral bimatoprost implant 10\u00a0\u00b5g and selective laser trabeculoplasty. Am J Ophthalmol. 2025;272:19\u201337.","journal-title":"Am J Ophthalmol"},{"key":"1408_CR18","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.2147\/OPTH.S276124","volume":"14","author":"A Al Habash","year":"2020","unstructured":"Al Habash A, Nagshbandi AA. Quality of life after combined cataract and minimally invasive glaucoma surgery in glaucoma patients. Clin Ophthalmol Auckl. 2020;14:3049\u201356.","journal-title":"Clin Ophthalmol Auckl"},{"key":"1408_CR19","doi-asserted-by":"publisher","unstructured":"Jones L, Maes N, Qidwai U, Ratnarajan G. Impact of minimally invasive glaucoma surgery on the ocular surface and quality of life in patients with glaucoma. Ther Adv Ophthalmol. 2023;15. https:\/\/doi.org\/10.1177\/25158414231152765.","DOI":"10.1177\/25158414231152765"},{"issue":"9","key":"1408_CR20","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.ophtha.2024.02.022","volume":"131","author":"SR Sarkisian","year":"2024","unstructured":"Sarkisian SR, Ang RE, Lee AM, et al. Phase\u00a03 randomized clinical trial of the safety and efficacy of travoprost intraocular implant in patients with open-angle glaucoma or ocular hypertension. Ophthalmology. 2024;131(9):1021\u201332.","journal-title":"Ophthalmology"},{"issue":"4","key":"1408_CR21","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s40123-024-00898-y","volume":"13","author":"SR Sarkisian","year":"2024","unstructured":"Sarkisian SR, Ang RE, Lee AM, et al. Travoprost intracameral implant for open-angle glaucoma or ocular hypertension: 12-month results of a randomized, double-masked trial. Ophthalmol Ther. 2024;13(4):995\u20131014.","journal-title":"Ophthalmol Ther"},{"key":"1408_CR22","volume":"17","author":"IP Singh","year":"2025","unstructured":"Singh IP, Voskanyan LA, Barber KM, et al. Safety and efficacy of travoprost intracameral implant administered in combination with cataract surgery. Ther Adv Ophthalmol. 2025;17:25158414241310276.","journal-title":"Ther Adv Ophthalmol"},{"key":"1408_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/OPTH.S498431","volume":"19","author":"S Teymoorian","year":"2025","unstructured":"Teymoorian S, Kaur J. Travoprost intracameral implant in eyes with glaucoma or ocular hypertension: early short-term real-world outcomes. Clin Ophthalmol Auckl. 2025;19:157\u201366.","journal-title":"Clin Ophthalmol Auckl"},{"issue":"1","key":"1408_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/IJG.0000000000002141","volume":"32","author":"SR Sarkisian","year":"2023","unstructured":"Sarkisian SR, Grover DS, Gallardo MJ, et al. Effectiveness and safety of iStent infinite trabecular micro-bypass for uncontrolled glaucoma. J Glaucoma. 2023;32(1):9\u201318.","journal-title":"J Glaucoma"},{"key":"1408_CR25","doi-asserted-by":"crossref","unstructured":"Shultz M, Vest ZM, Trubnik V, Sarkisian SR, Hornbeak DM. Third-generation trabecular micro-bypass implantation and phacoemulsification in patients with glaucoma: a multicenter study. Vision (Switzerland). 2025;9(3):61.","DOI":"10.3390\/vision9030061"},{"issue":"3","key":"1408_CR26","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s40123-024-01087-7","volume":"14","author":"Z Vest","year":"2025","unstructured":"Vest Z, Alinaghizadeh N, Prendergast C. Third-generation trabecular micro-bypass implantation with phacoemulsification for glaucoma. Ophthalmol Ther. 2025;14(3):529\u201339.","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"1408_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5005\/jp-journals-10078-1508","volume":"20","author":"N Koerber","year":"2026","unstructured":"Koerber N, Ondrejka S. Safety and effectiveness outcomes of ab interno canaloplasty in open-angle glaucoma: 10-year results. J Curr Glaucoma Pract. 2026;20(1):11\u20133.","journal-title":"J Curr Glaucoma Pract"},{"key":"1408_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ajo.2026.01.010","volume":"284","author":"N Kerr","year":"2026","unstructured":"Kerr N, Lubeck D, Barton K, et al. A prospective, real-world, multicenter study to support the role of ab-interno canaloplasty in glaucoma management. Am J Ophthalmol. 2026;284:235\u201346.","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"1408_CR29","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/IJG.0000000000002616","volume":"34","author":"D Zhu","year":"2025","unstructured":"Zhu D, Shah P, Zhang C, et al. Standalone canaloplasty and trabeculotomy using the OMNI surgical system in patients with open angle glaucoma: a systematic review and meta-analysis. J Glaucoma. 2025;34(11):949\u201358.","journal-title":"J Glaucoma"},{"issue":"5","key":"1408_CR30","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s10792-022-02553-6","volume":"43","author":"DC Terveen","year":"2022","unstructured":"Terveen DC, Sarkisian SR Jr, Vold SD, et al. Canaloplasty and trabeculotomy with the OMNI\u00ae surgical system in OAG with prior trabecular microbypass stenting. Int Ophthalmol. 2022;43(5):1647\u201356. https:\/\/doi.org\/10.1007\/s10792-022-02553-6.","journal-title":"Int Ophthalmol"},{"issue":"1","key":"1408_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40123-024-01073-z","volume":"14","author":"JM Micheletti","year":"2025","unstructured":"Micheletti JM, Shultz M, Singh IP, Samuelson TW. An emerging multi-mechanism and multi-modal approach in interventional glaucoma therapy. Ophthalmol Ther. 2025;14(1):13\u201322.","journal-title":"Ophthalmol Ther"},{"issue":"17","key":"1408_CR32","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s40265-021-01624-9","volume":"81","author":"J Bacharach","year":"2021","unstructured":"Bacharach J, Tatham A, Ferguson G, et al. Phase\u00a03, randomized, 20-month study of the efficacy and safety of bimatoprost implant in patients with open-angle glaucoma and ocular hypertension (ARTEMIS 2). Drugs. 2021;81(17):2017\u201333.","journal-title":"Drugs"},{"issue":"12","key":"1408_CR33","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.ophtha.2020.06.018","volume":"127","author":"FA Medeiros","year":"2020","unstructured":"Medeiros FA, Walters TR, Kolko M, et al. Phase\u00a03, randomized, 20-month study of bimatoprost implant in open-angle glaucoma and ocular hypertension (ARTEMIS 1). Ophthalmology. 2020;127(12):1627\u201341.","journal-title":"Ophthalmology"},{"key":"1408_CR34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ajo.2024.07.034","volume":"270","author":"PHS Yuan","year":"2025","unstructured":"Yuan PHS, Dorling M, Shah M, Panarelli JF, Durr GM. Combined microinvasive glaucoma surgery with phacoemulsification in open-angle glaucoma: a systematic review and meta-analysis. Am J Ophthalmol. 2025;270:154\u201363.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"1408_CR35","doi-asserted-by":"publisher","first-page":"e0183142","DOI":"10.1371\/journal.pone.0183142","volume":"12","author":"C Lavia","year":"2017","unstructured":"Lavia C, Dallorto L, Maule M, Ceccarelli M, Fea AM. Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: a systematic review and meta-analysis. PLoS ONE. 2017;12(8):e0183142.","journal-title":"PLoS ONE"},{"key":"1408_CR36","unstructured":"Glaukos Corporation.iStent Infinite trabecular micro-bypass system: instructions for use. San Clemente, CA; 2024. https:\/\/www.glaukos.com\/wp-content\/uploads\/2024\/04\/P-000128-Rev-1-IFU-iS3-iStent-infinite-Commercial-AU.pdf. Accessed 29 Jan 2026."},{"key":"1408_CR37","unstructured":"Glaukos Corporation.iDose Prescribing Information. San Clemente, CA"},{"key":"1408_CR38","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2147\/OPTH.S177597","volume":"12","author":"MJ Gallardo","year":"2018","unstructured":"Gallardo MJ, Supnet RA, Ahmed IIK. Viscodilation of Schlemm\u2019s canal for the reduction of IOP via an ab-interno approach. Clin Ophthalmol (Auckl). 2018;12:2149\u201355.","journal-title":"Clin Ophthalmol (Auckl)"},{"key":"1408_CR39","first-page":"3641","volume":"14","author":"T Hughes","year":"2020","unstructured":"Hughes T, Traynor M. Clinical results of ab interno canaloplasty in patients with open-angle glaucoma. Clin Ophthalmol (Auckl). 2020;14:3641\u201350.","journal-title":"Clin Ophthalmol (Auckl)"},{"issue":"10","key":"1408_CR40","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268\u201379.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"1408_CR41","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","volume":"29","author":"RD Fechtner","year":"2010","unstructured":"Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea. 2010;29(6):618\u201321.","journal-title":"Cornea"},{"issue":"6","key":"1408_CR42","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ophtha.2019.03.006","volume":"126","author":"TW Samuelson","year":"2019","unstructured":"Samuelson TW, Sarkisian SRJ, Lubeck DM, et al. Prospective, randomized, controlled pivotal trial of an ab interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results. Ophthalmology. 2019;126(6):811\u201321.","journal-title":"Ophthalmology"},{"key":"1408_CR43","first-page":"1","volume":"2026","author":"N Kerr","year":"2026","unstructured":"Kerr N, Ratnarajan G, Wang J, et al. Multicentre study comparing ab-interno canaloplasty and trabecular micro-bypass stent in primary open-angle glaucoma. Eye. 2026;2026:1\u20139.","journal-title":"Eye"},{"key":"1408_CR44","unstructured":"Jay Katz L, Sarkisian S, Voskanyan L, et al. Results of the prospective, randomized, controlled, multi-center phase\u00a03 trials of the travoprost intraocular implant versus topical timolol. In: ARVO annual meeting. New Orleans, LA: Association for Research in Vision and Ophthalmology; 2023. https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2788577 Accessed 29 Jan 2026."},{"issue":"10","key":"1408_CR45","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s40265-024-02074-9","volume":"84","author":"IP Singh","year":"2024","unstructured":"Singh IP, Berdahl JP, Sarkisian SR, et al. Long-term safety and efficacy evaluation of travoprost intracameral implant based on pooled analyses from two phase\u00a0III trials. Drugs. 2024;84(10):1299\u2013311.","journal-title":"Drugs"},{"issue":"6","key":"1408_CR46","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/IJG.0000000000000643","volume":"26","author":"JJ Armstrong","year":"2017","unstructured":"Armstrong JJ, Wasiuta T, Kiatos E, Malvankar-Mehta M, Hutnik CML. The effects of phacoemulsification on intraocular pressure and topical medication use in patients with glaucoma: a systematic review and meta-analysis of 3-year data. J Glaucoma. 2017;26(6):511\u201322.","journal-title":"J Glaucoma"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01408-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01408-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01408-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:26:00Z","timestamp":1782739560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01408-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1408"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01408-y","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Chloe CoHan reports no conflicts of interest. Christine Funke reports the following conflicts of interest: Abbvie\u2014consultant and speaker, Alcon\u2014consultant, speaker, research grants\/investigator, Glaukos\u2014consultant and speaker, Thea\u2014consultant, Sight Sciences\u2014consultant, speaker and research investigator, Dompe\u2014consultant, New World Medical-consultant, Nova Eye Medical\u2014consultant and speaker, Elios-marketing board member, consultant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The analysis was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. The study protocol was reviewed and approved by the Advarra ethics committee. While all patients gave informed consent to undergo surgery prior to the procedure, a separate informed consent for later inclusion in this chart review was waived given this was a retrospective anonymized analysis of existing clinical data (Waiver Pro#00093225).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}